PERSISTENCE OF INTRAMUSCULAR VERSUS SUBCUTANEOUS FIRST-LINE THERAPIES IN MULTIPLE SCLEROSIS PATIENTS

PERSISTENCE OF INTRAMUSCULAR VERSUS SUBCUTANEOUS FIRST-LINE THERAPIES IN MULTIPLE SCLEROSIS PATIENTS